Cargando…

Anti-TIF1γ antibody predicted malignancy of thymic tumor with dermatomyositis as an “autoimmune tumor marker”: A case report

RATIONALE: An association between inflammatory myopathy and malignancy has been recognized particularly in patients positive for anti-transcription intermediary factor 1γ (TIF1γ) antibody. We report a case of anti-TIF1γ antibody positive dermatomyositis (DM) associated with thymic carcinoma which ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karino, Kohei, Fujieda, Yuichiro, Kawamura, Takuya, Abe, Nobuya, Shimoyama, Shuhei, Kono, Michihito, Kato, Masaru, Yasuda, Shinsuke, Atsumi, Tatsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310527/ https://www.ncbi.nlm.nih.gov/pubmed/30544475 http://dx.doi.org/10.1097/MD.0000000000013563

Ejemplares similares

Cytokine and chemokine multiplex analysis-based exploration for potential treatment and prognostic prediction in large-vessel vasculitis: A preliminary observational study
por: Abe, Nobuya, et al.
Publicado: (2022)

A case report dysregulated neutrophil extracellular traps in a patient with propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Watanabe-Kusunoki, Kanako, et al.
Publicado: (2019)

Itaconate ameliorates autoimmunity by modulating T cell imbalance via metabolic and epigenetic reprogramming
por: Aso, Kuniyuki, et al.
Publicado: (2023)

1. TIF1-γ associated dermatomyositis
por: Waller, Rosemary, et al.
Publicado: (2019)

HLA-B52-positive Aortitis with Antineutrophil Cytoplasmic Antibody-associated Vasculitis
por: Karino, Kohei, et al.
Publicado: (2016)

Autoantibodies to transcription intermediary factor (TIF)1β associated with dermatomyositis
por: Satoh, Minoru, et al.
Publicado: (2012)

Prominent dyspigmentation in a patient with dermatomyositis and TIF1-γ autoantibodies
por: Gutierrez, Daniel, et al.
Publicado: (2022)

Myositis-specific Autoantibodies Reacting to Both Tif1gamma and Mi-2 in a Patient with Juvenile Dermatomyositis
por: TAKEZAKI, Daiki, et al.
Publicado: (2020)

Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
por: Nakanishi, Yu, et al.
Publicado: (2020)

Kasabach–Merritt phenomenon with concurrent appearance of antiphospholipid antibodies in a patient with giant liver haemangioma
por: Nakamura, Hiroyuki, et al.
Publicado: (2018)

A unique case of dermatomyositis associated with anti-TIF1γ antibody and chondrosarcoma
por: Dziwis, Jennifer, et al.
Publicado: (2019)

Analysis of human total antibody repertoires in TIF1γ autoantibody positive dermatomyositis
por: Megremis, Spyridon, et al.
Publicado: (2021)

Clinical Characteristics of Anti-TIF-1γ Antibody-Positive Dermatomyositis Associated with Malignancy
por: Harada, Yumi, et al.
Publicado: (2022)

Anti-TIF1gamma Antibody-Positive Dermatomyositis Associated with Myelodysplastic Syndrome: Response to Treatment
por: Lerman, Irina, et al.
Publicado: (2019)

Dermatomyositis with positive anti‐TIF1 gamma antibodies in an adult female: A case report
por: Adhikari, Krishna, et al.
Publicado: (2023)

Decreased haptoglobin levels inversely correlated with pulmonary artery pressure in patients with pulmonary arterial hypertension: A cross-sectional study
por: Nakamura, Hiroyuki, et al.
Publicado: (2017)

AB019. Response to tofacitinib in a case of refractory TIF-1 positive amyopathic dermatomyositis with arthritis
por: Jasmine, Sion Ward, et al.
Publicado: (2021)

Paraneoplastic Anti-Tif1-gamma Autoantibody-positive Dermatomyositis as Clinical Presentation of Hepatocellular Carcinoma Recurrence
por: Ferronato, Marco, et al.
Publicado: (2023)

Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1-γ-Positive Dermatomyositis
por: Wu, Chih-Feng, et al.
Publicado: (2023)

AAA-ATPase p97 suppresses apoptotic and autophagy-associated cell death in rheumatoid arthritis synovial fibroblasts
por: Kato, Masaru, et al.
Publicado: (2016)

Non-tuberculosis Mycobacterium Tenosynovitis with Rice Bodies in a Patient with Systemic Lupus Erythematosus
por: Fujieda, Yuichiro, et al.
Publicado: (2020)

NanoString technology distinguishes anti‐TIF‐1γ(+) from anti‐Mi‐2(+) dermatomyositis patients
por: Preusse, Corinna, et al.
Publicado: (2021)

Marked Improvement of Anti-TIF1-γ Antibody-Positive Dermatomyositis After Chemoradiotherapy to Relevant Nasopharyngeal Cancer
por: Tomita, Natsuo, et al.
Publicado: (2021)

Reversible Diffuse Bronchial Wall Thickening
por: Aso, Kuniyuki, et al.
Publicado: (2022)

Anti‐TIF1γ antibody‐positive dermatomyositis associated with durvalumab administration in a patient with lung and oesophageal cancers
por: Imai, Ryosuke, et al.
Publicado: (2021)

ELISA, protein immunoprecipitation and line blot assays for anti-TIF1-gamma autoantibody detection in cancer-associated dermatomyositis
por: Selickaja, Sandra, et al.
Publicado: (2022)

Rapidly progressive interstitial lung disease combined with pneumocystis jiroveci pneumonia in a patient with single anti-TIF-1γ antibody positive dermatomyositis in the context of an underlying tumor
por: Zhang, Hengzhe, et al.
Publicado: (2023)

The Association between TIF1 Family Members and Cancer Stemness in Solid Tumors
por: Czerwinska, Patrycja, et al.
Publicado: (2021)

Genetic background may contribute to the latitude-dependent prevalence of dermatomyositis and anti-TIF1-γ autoantibodies in adult patients with myositis
por: Parkes, Joanna E., et al.
Publicado: (2018)

Tracker ready for transport at TIF
por: Hoch, Michael
Publicado: (2007)

Dermatomyositis with anti-TIF-1γ antibodies as a presenting symptom of underlying triple-negative breast cancer: a case report
por: Kubeček, Ondřej, et al.
Publicado: (2016)

OA29 Blotting-based assays under-detected TIF1-gamma and NXP2 autoantibodies compared to immunoprecipitation in Juvenile Dermatomyositis cohorts
por: Nguyen, Huong D, et al.
Publicado: (2022)

Prognostic role of Tif1γ expression and circulating tumor cells in patients with breast cancer
por: Cai, Fengfeng, et al.
Publicado: (2019)

The CMS Tracker support tube in the TIF.
por: Michael Eppard
Publicado: (2005)

Transport of the Tracker from TIF to CMS
por: Hoch, Michael
Publicado: (2007)

The evolution of TIF: transoral incisionless fundoplication
por: Ihde, Glenn M.
Publicado: (2020)

The Roles of TIF1γ in Cancer
por: Yu, Chengpeng, et al.
Publicado: (2019)

Successful treatment of thymic carcinoma with dermatomyositis and interstitial pneumonia: A case report
por: Yang, Xingguo, et al.
Publicado: (2019)

Inactivation of TIF1γ Cooperates with Kras(G12D) to Induce Cystic Tumors of the Pancreas
por: Vincent, David F., et al.
Publicado: (2009)

Tumor immunity is related to (18)F‐FDG uptake in thymic epithelial tumor
por: Imai, Hisao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1rv05c9padigu0o8gvachri9fb